SCHEMBL7812893

SCHEMBL7812893

Cc1ccc(-c2nc3c(s2)C(=O)c2ccc(F)cc2C3=O)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 5/20 0.51
TDO2 P48775 3/20 0.51
AR P10275 1/20 0.44
APP P05067 2/20 0.43
PTGS2 P35354 5/20 0.42
USP8 P40818 1/20 0.40
USP7 Q93009 1/20 0.40
USP47 Q96K76 1/20 0.40
PTGS1 P23219 1/20 0.40
RORC P51449 2/20 0.38
ALOX5 P09917 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GLA P06280 1/20 0.38
HSP90AA1 P07900 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7812596 1.00 IDO1 (0.51) IDO1TDO2ARAPPPTGS2
SCHEMBL7812894 0.92 IDO1 (0.56) IDO1TDO2ARAPPPTGS2
SCHEMBL7815327 0.92 IDO1 (0.56) IDO1TDO2ARAPPPTGS2
SCHEMBL7805861 0.87 IDO1 (0.60) IDO1TDO2ARPTGS2USP8
SCHEMBL7805662 0.87 IDO1 (0.60) IDO1TDO2ARPTGS2USP8
SCHEMBL7808005 0.82 IDO1 (0.60) IDO1TDO2PTGS2USP8USP7
SCHEMBL7805807 0.82 IDO1 (0.60) IDO1TDO2PTGS2USP8USP7
SCHEMBL7805767 0.81 IDO1 (0.71) IDO1TDO2PTGS2PTGS1ALOX5
SCHEMBL7815314 0.79 IDO1 (0.40) IDO1TDO2PTGS2USP8USP7
SCHEMBL7813067 0.79 IDO1 (0.40) IDO1TDO2PTGS2USP8USP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 EP claimed
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 EP disclosed
US-6262095-B1 TREATMENT OF ILLNESS ASSOCIATED WITH AN ALTERATION IN VENOUS FUNCTION AND/OR INFLAMMATORY EDEMA LABORATOIRE INNOTHERA (FR) 2001-07-17 US disclosed